Jennifer Jain is a Neurology physician. OpenAlex indexes 84 publications with 1,004 citations (h-index 21); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
13330 Usf Laurel Dr
Tampa, FL 336126601
Telephone
813-821-8038Provider last certified this registry record 17 Feb 2022.
Clinical trials
- Wellness, Intervention Strategies and HIV Care
Sponsor: University of California, San Francisco
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20251 payment$20,000openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year20252 payments
- Boston Scientific CorporationProgram year20241 payment$20,000openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
88.9%Neuromuscular Blocker88.9%Onabotulinumtoxina100%Part B, office-administered≥22 patientsNervous system
9.8%Aromatic Amino Acid Decarboxylation Inhibitor4.3%Carbidopa-Levodopa86%Carbidopa-Levodopa Er11%Carbidopa3%Part D<11 patientsNonergot Dopamine Agonist1.1%Pramipexole Dihydrochloride72%Ropinirole Hcl16%Neupro12%Part D<11 patients+ 15 more classes in this area
Cardiovascular
1.1%Beta blocker1.1%Propranolol Hcl100%Part D≥42 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Co-Utilization of HIV, Substance Use, Mental Health Services Among Women With Current Substance Use: Opportunities for Integrated Care?
Journal of Primary Care & Community Health
2024 - Prevalence and Correlates of SARS-CoV-2 Vaccine Uptake and Hesitancy Among People With HIV Across the United States
JAIDS Journal of Acquired Immune Deficiency Syndromes
2024 - Deep brain stimulation for chronic pain: a systematic review and meta-analysis
Frontiers in Human Neuroscience
2023 - “If you're strung out and female, they will take advantage of you”: A qualitative study exploring drug use and substance use service experiences among women in Boston and San Francisco
Journal of Substance Use and Addiction Treatment
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”